These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 12728666

  • 1. [Increased thrombin-genesis in cyclosporine A-treated idiopathic nephrotic syndrome in children].
    Tkaczyk M, Owczarek D, Nowicki M.
    Pol Merkur Lekarski; 2003 Feb; 14(80):106-9. PubMed ID: 12728666
    [Abstract] [Full Text] [Related]

  • 2. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M, Owczarek D, Finke D, Nowicki M.
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
    Saeed B, Ossman MI, Sheriff S.
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 5. [Activation of coagulation cascade in children during an idiopathic nephrotic syndrome relapse].
    Tkaczyk M, Owczarek D, Puczko-Nogal B, Makosiej R, Rogowska-Kalisz A, Ptaśnik W, Finke D.
    Pol Merkur Lekarski; 2000 Apr; 8(46):226-7. PubMed ID: 10897622
    [Abstract] [Full Text] [Related]

  • 6. [Assessment of the peripheral circulation in children with nephrotic syndrome treated with cyclosporin A].
    Czupryniak A, Kałuzyńska A, Tkaczyk M, Półtorak-Krawczyk A, Ostrowski B, Wiecek B, Nowicki M.
    Przegl Lek; 2006 Apr; 63 Suppl 3():214-6. PubMed ID: 16898534
    [Abstract] [Full Text] [Related]

  • 7. Surface markers of platelet function in idiopathic nephrotic syndrome in children.
    Tkaczyk M, Baj Z.
    Pediatr Nephrol; 2002 Aug; 17(8):673-7. PubMed ID: 12185480
    [Abstract] [Full Text] [Related]

  • 8. [Oxidative potential of neutrophils in cyclosporine A treated children with idiopathic nephrotic syndrome].
    Tkaczyk M, Lewkowicz P, Nowicki M, Tchórzewski H, Baj Z.
    Pol Merkur Lekarski; 2004 Oct; 17(100):331-4. PubMed ID: 15690694
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 10. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 11. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF, Brodeh J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin A does not affect platelets in children with idiopathic nephrotic syndrome.
    Tkaczyk M, Baj Z, Nowicki M.
    Pediatr Nephrol; 2005 Jan; 20(1):30-5. PubMed ID: 15517412
    [Abstract] [Full Text] [Related]

  • 13. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P, Bezerra Da Silva G, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB.
    J Nephrol; 2005 Jan; 18(6):711-20. PubMed ID: 16358229
    [Abstract] [Full Text] [Related]

  • 14. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 15. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Feb; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 16. [Platelet activation in relapse idiopathic nephrotic syndrome in children].
    Tkaczyk M, Baj Z, Nowicki M.
    Pol Merkur Lekarski; 2001 Apr; 10(58):229-32. PubMed ID: 11434163
    [Abstract] [Full Text] [Related]

  • 17. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 18. Concomitant administration of cyclosporine and ketoconazole in idiopathic nephrotic syndrome.
    El-Husseini A, El-Basuony F, Donia A, Mahmoud I, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2266-71. PubMed ID: 15238631
    [Abstract] [Full Text] [Related]

  • 19. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome.
    Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M.
    Am J Nephrol; 2008 Sep; 28(2):197-202. PubMed ID: 17962717
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F, Ahmad TM, Anwar S.
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.